None listed
Conditions
Interventions
Intervention1: Vitamin D tablets: Vitamin D tablets of varying doses (200 IU/d, 400 IU/d, 600 IU/d, 800 IU/d) in each subgroup will be provided for 12 week intervention period
In vitamin D sufficient
Sponsors
Department of Biotechnology Government of India
Eligibility
Inclusion criteria
Inclusion criteria: Non pregnant non lactating women Female volunteers Age 35 years 25-OHD deficient 30 ng/mL
Exclusion criteria
Exclusion criteria: Pregnant and lactating women Age >18 and Any disease or chronic illness Recent history (3 months prior) of serious infection, injuries and/or surgeries Any food allergy or food intolerance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Optimization of dose levels for Vit D supplementation and plasma Vit D levels, using changes in bone resorption rateTimepoint: 3:Baseline,Midpoint,Endline | — |
Secondary
| Measure | Time frame |
|---|---|
| The study would help in establishing bone resorption rate and the derived BMB that is directly linked with bone health, as a new marker for Vit D supplementation efficacy studies. Ca bio-availability measurements in Vit D deficient and sufficient states. This is important for defining Vit D and Calcium supplementation needed Timepoint: 3:Baseline,Midpoint,Endline | — |
Countries
India
Contacts
Public ContactDr Prashanth Thankachan
St Johns Research Institute
Outcome results
None listed